Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2000
11/28/2000US6153595 Composition and method for treatment of CMV infections
11/28/2000US6153433 Suppressing microorganismal propagation; insertion of nucleotide sequences coding viricidal polypeptide into cells infected with hepatitis viral agent, monitor for propagation
11/28/2000US6153428 α(1,3) galactosyltransferase negative porcine cells
11/28/2000US6153425 Apparatus for the isolation and amplification nucleotide sequences; for the accurate and efficient detection of nucleotide sequences
11/28/2000US6153402 Death domain containing receptors
11/28/2000US6153382 Viral growth inhibition
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
11/28/2000CA2074681C Genetic engineering process for the production of s-(+)-2,2-dimethylcyclopropanecarboxamide by microorganisms
11/23/2000WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION
11/23/2000WO2000070087A1 Automated nucleic acid compaction device
11/23/2000WO2000070069A1 Acquired resistance genes in plants
11/23/2000WO2000069883A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
11/23/2000WO2000069878A1 Universal solid supports suitable for the synthesis of nucleic acids
11/23/2000WO2000069872A2 pH DEPENDENT ION EXCHANGE MATRIX AND METHOD OF USE IN THE ISOLATION OF NUCLEIC ACIDS
11/23/2000WO2000069450A1 Oncogene identification by transformation of rk3e cells and uses thereof
11/23/2000WO2000040330A3 Device for carrying out chemical reactions
11/23/2000WO2000029420A3 Methods of making modified nucleosides
11/23/2000WO2000022169A9 DETECTION USING Snz AND Sno GENES AND PROTEINS
11/23/2000WO1999004775A3 Method of treating dopaminergic and gaba-nergic disorders
11/23/2000DE19923571A1 New plant promoter containing cis-acting elements, useful for producing transgenic plants with increased tolerance of pathogens, particularly fungi
11/23/2000DE19923168A1 Neue Fluoreszenzfarbstoffe und ihre Verwendung als Fluoreszenzmarker New fluorescent dyes and their use as fluorescent markers
11/23/2000CA2373243A1 Automated nucleic acid compaction device
11/23/2000CA2372654A1 Acquired resistance genes in plants
11/23/2000CA2372323A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
11/23/2000CA2372054A1 Ph dependent ion exchange matrix and method of use in the isolation of nucleic acids
11/22/2000EP1054039A1 Fluorescent dyes and their use as fluorescent labelling agents
11/22/2000EP1053460A2 An automatic method of classifying molecules
11/22/2000EP1053355A2 Pna and dna conjugates and methods for preparation thereof
11/22/2000EP1053353A1 Eluting reagents, methods and kits for isolating dna
11/22/2000EP1053313A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences
11/22/2000CN1274361A Solution phase synthesis of oligonucleotides
11/21/2000US6150588 DNA encoding antimicrobial proteins from impatiens
11/21/2000US6150516 Solid phase supports, each having spatially discrete regions, each region having uniform population of identical tag complements selected from single mimimally cross-hybridizing set of oligonucleotides; large scale sequencing and analysis
11/21/2000US6150510 Modified oligonucleotides, their preparation and their use
11/21/2000US6150339 Anti-viral guanosine-rich oligonucleotides
11/21/2000US6150150 Human brain phosphodiesterase
11/21/2000US6150147 Laying out a pattern of nucleotide sequences on surface of a substrate; forming layout of nucleic acid sequences on the surface of a substrate and reducing electrostatic charge during process
11/21/2000US6150116 Transcription factor DP-1 antibody
11/21/2000US6150099 Detecting modulators of transcription factors; incubating transcription factor and modulator in solution, monitor the level of gene expression
11/21/2000US6150097 Nucleic acid detection probes having non-FRET fluorescence quenching and kits and assays including such probes
11/21/2000CA2089362C Methods of synthesizing oligonucleotides with random codons
11/16/2000WO2000068689A1 Cell separation device and methods for use
11/16/2000WO2000068241A1 Processes for the synthesis of oligomers using phusphoramidite compositions
11/16/2000WO2000067894A2 Methods of software driven flow sorting for reiterative synthesis cycles
11/16/2000WO2000036110A3 Plant disease resistance genes
11/16/2000WO2000029561A3 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
11/16/2000WO2000009706A3 Maize cellulose synthases and uses thereof
11/16/2000DE19919607A1 Parallel synthesis of multiple oligonucleotides comprises using plug-in modules rotating between stations for performing different operations
11/15/2000EP1052264A2 Process for the synthesis of nucleoside analogs
11/15/2000EP1051520A1 Improved method for the isolation of nucleic acid
11/15/2000EP1051513A1 Polymeric arrays and methods for their use in binding assays
11/15/2000EP1051500A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/15/2000EP1051430A2 Array fabrication methods
11/15/2000EP1051424A1 Novel synthons for oligonucleotide synthesis
11/15/2000EP0771359A4 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors
11/14/2000US6147205 Arylalkyloxycarbonyl groups; for solid phase synthesis of oligonucleotides and polypeptides
11/14/2000US6147204 Complex for targeting therapeutic or diagnostic agents to preferential biological target
11/14/2000US6147202 Nucleotide sequences coding erythrocyte proteins; for utilization in blood transfusions
11/14/2000US6147200 2'-O-acetamido modified monomers and oligomers
11/14/2000US6147199 Viricides
11/14/2000US6147190 Protein associated with activating cell propagation; for the treatment of a nervous system disorders; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147056 Therapy for psoriasis
11/14/2000US6146886 RNA polymerase III-based expression of therapeutic RNAs
11/14/2000US6146862 Thermostable diaphorase gene
11/14/2000US6146833 Polymeric reagents for immobilizing biopolymers
11/14/2000US6146829 Gapped 2' modified oligonucleotides
11/14/2000US6146634 Proteins with urease activity
11/14/2000US6146511 Electrophoretic nucleic acid purification method
11/14/2000CA2105912C Nadh and nadph as drugs for treating alzheimer's disease
11/14/2000CA1341140C Structural phosphoprotein (pp28) of human cytomegalovirus (hcmv), the preparation and use thereof
11/11/2000CA2307951A1 Process for the synthesis of nucleoside analogs
11/10/2000CA2307446A1 Complex for transferring an anionic substance of interest into a cell
11/09/2000WO2000066609A1 Oligonucleotides having a-dna form and b-dna form conformational geometry
11/09/2000WO2000066607A1 Detection using degradation of a tagged sequence
11/09/2000WO2000066605A2 Polynucleotides
11/09/2000WO2000066604A2 L-ribo-lna analogues
11/09/2000WO2000066360A1 Multiple fluid sample processor with single well addressability
11/09/2000WO2000066259A1 Method and apparatus for combinatorial chemistry
11/09/2000WO2000040592A8 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
11/09/2000WO2000040525A3 Polymer arrays and methods of making and using same
11/09/2000CA2718662A1 Rapid and efficient capture of dna from sample without using cell lysing reagent
11/09/2000CA2373225A1 Oligonucleotides having a-dna form and b-dna form conformational geometry
11/09/2000CA2368581A1 Detection using degradation of a tagged sequence
11/08/2000EP1049803A1 Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
11/08/2000EP1049801A1 Method for isolating and purifying nucleic acids on surfaces
11/08/2000EP1049772A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
11/08/2000EP1049744A1 Asymmetric cyanine dye quenchers
11/08/2000EP0936951A4 Methods for producing low binding surfaces
11/08/2000CN1272546A New human neuronal protein and its coded sequence
11/08/2000CN1272545A Human neurogenic glutamine transport protein and its coded sequence
11/08/2000CN1272544A Human bladder protein and its coded sequence
11/08/2000CN1272543A Human gene expression regulatory factor related protein and its coded sequence
11/08/2000CN1272542A Human protein phosphoglycan protein and its coded sequence
11/08/2000CN1272541A Human trans-Golgi network protein isomer and its coded sequence
11/08/2000CN1272540A Human immune factor related protein and its coded sequence
11/08/2000CN1272539A Human cytodiaeresis inhibition factor protein and its coded sequence
11/07/2000US6143881 Antisense agents with superior properties of duplex formation with rna, nuclease resistance, and ribonuclease h activation; viricides against human immunodeficiency virus
11/07/2000US6143879 Nucleotide cleaving agents and method
11/07/2000US6143877 Oligonucleotides including pyrazolo[3,4-D]pyrimidine bases, bound in double stranded nucleic acids
11/07/2000US6143865 Amino acid sequences which are reactive with viral antibodies; for accurate and sensitive immunoassay diagnosis
1 ... 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 ... 899